Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of RO7812653 in adults with early symptomatic Alzheimer'…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• RO7812653

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Alzheimer's Disease | Phase 1 | Status: RECRUITING